Work

Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps666

Authors: Kevin Kalinsky, Dow-Chung Chi, Shing Mirn Lee, Kerin B. Adelson, Katherine D. Crew, Ellen Chuang, Della Makower, Dawn L. Hershman, Andrea Califano, Jose Silva, Matthew A. Maurer

Institutions: Columbia University Irving Medical Center, Columbia University, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, Albert Einstein College of Medicine, Montefiore Medical Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2533070945

Cites:

Cited by: 2

Related to: 10